Literature DB >> 6632128

Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry.

D T Durack, E L Kaplan, A L Bisno.   

Abstract

Fifty-two cases of apparent endocarditis prophylaxis failure were reported to a national registry established by the American Heart Association (AHA). Mitral valve prolapse was the single most common underlying cardiac lesion (17 cases, 33%), followed by various congenital abnormalities (15 cases, 29%) and rheumatic heart disease (11 cases, 21%). Ten patients (19%) had prosthetic valve endocarditis. Forty-eight cases (92%) occurred after a dental procedure. Symptoms began within two weeks after the procedure suspected to have caused endocarditis in 50% and within five weeks in 79%. Thirty-nine cases (75%) were caused by viridans streptococci and seven (14%) by Staphylococcus aureus. Most patients received oral penicillin as prophylaxis. Only six patients (12%) received regimens currently recommended by the AHA. In 27 (63%) of the 43 cases for which antimicrobial susceptibility data were available, the infecting microorganism was sensitive to the antibiotic(s) used for prophylaxis. After diagnosis of endocarditis, the prognosis for bacteriologic cure was good; 47 patients (90%) were cured, of whom seven underwent valve replacement. These data indicate that endocarditis prophylaxis failures may be more common than was previously believed and that failures occur even when the infecting organism is susceptible to the antibiotics used. Most antimicrobial regimens used in patients with prophylaxis failures did not conform to current recommendations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6632128

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  24 in total

Review 1.  Antimicrobial prophylaxis.

Authors:  J Smith; A Finn
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

2.  Dentistry and Endocarditis.

Authors:  Michael J Wahl; Thomas J Pallasch
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

3.  Gemella bergeriae sp. nov., isolated from human clinical specimens.

Authors:  M D Collins; R A Hutson; E Falsen; B Sjöden; R R Facklam
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 4.  Infective endocarditis during infancy and childhood: current status.

Authors:  S K Sanyal; M A Saleh; A Abu-Melha
Journal:  Indian J Pediatr       Date:  1988 Jan-Feb       Impact factor: 1.967

5.  Use of groESL as a target for identification of Abiotrophia, Granulicatella, and Gemella species.

Authors:  Wei-Chun Hung; Sung-Pin Tseng; Hsiao-Jan Chen; Jui-Chang Tsai; Chih-Hsin Chang; Tai-Fen Lee; Po-Ren Hsueh; Lee-Jene Teng
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

6.  Cost effectiveness of prophylaxis in dental practice to prevent infective endocarditis.

Authors:  I M Gould; J K Buckingham
Journal:  Br Heart J       Date:  1993-07

7.  Prevalence of Gemella haemolysans on the pharyngeal mucosa of man.

Authors:  U Berger
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

8.  Computer-assisted flapless implant placement reduces the incidence of surgery-related bacteremia.

Authors:  Volkan Arısan; Nilüfer Bölükbaşı; Lütfiye Öksüz
Journal:  Clin Oral Investig       Date:  2012-12-06       Impact factor: 3.573

9.  Myocardial abscess with complete heart block complicating anaerobic infective endocarditis.

Authors:  H A Kopelman; B S Graham; M B Forman
Journal:  Br Heart J       Date:  1986-07

Review 10.  Recognition, management and prophylaxis of endocarditis.

Authors:  D Stamboulian; E Carbone
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.